DF Dent & Co. Inc. grew its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) by 5.8% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 339,839 shares of the company’s stock after purchasing an additional 18,736 shares during the quarter. DF Dent & Co. Inc. owned approximately 1.46% of OrthoPediatrics worth $15,051,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in KIDS. Point72 Hong Kong Ltd purchased a new position in shares of OrthoPediatrics during the first quarter worth about $26,000. Almanack Investment Partners LLC. purchased a new position in shares of OrthoPediatrics during the third quarter worth about $34,000. FMR LLC grew its holdings in shares of OrthoPediatrics by 71.7% during the first quarter. FMR LLC now owns 874 shares of the company’s stock worth $39,000 after buying an additional 365 shares during the last quarter. State of Wyoming grew its holdings in shares of OrthoPediatrics by 23.1% during the fourth quarter. State of Wyoming now owns 1,380 shares of the company’s stock worth $55,000 after buying an additional 259 shares during the last quarter. Finally, Lazard Asset Management LLC purchased a new position in shares of OrthoPediatrics during the first quarter worth about $65,000. Hedge funds and other institutional investors own 68.36% of the company’s stock.
OrthoPediatrics Stock Performance
NASDAQ:KIDS traded down $0.87 during mid-day trading on Monday, reaching $32.95. The stock had a trading volume of 64,714 shares, compared to its average volume of 101,939. The firm has a market capitalization of $769.38 million, a price-to-earnings ratio of 376.89 and a beta of 0.85. OrthoPediatrics Corp. has a twelve month low of $32.72 and a twelve month high of $53.50. The business has a 50 day simple moving average of $40.24 and a 200 day simple moving average of $43.34.
Analysts Set New Price Targets
KIDS has been the topic of a number of research reports. JMP Securities reissued a “market outperform” rating and set a $60.00 price target on shares of OrthoPediatrics in a report on Friday, September 1st. Needham & Company LLC reissued a “buy” rating and set a $55.00 price target on shares of OrthoPediatrics in a report on Tuesday, August 1st. Finally, Truist Financial lowered their price target on OrthoPediatrics from $57.00 to $51.00 and set a “buy” rating on the stock in a report on Wednesday, August 2nd. Four investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $53.60.
In related news, Director Terry D. Schlotterback sold 2,610 shares of OrthoPediatrics stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $38.25, for a total transaction of $99,832.50. Following the completion of the transaction, the director now directly owns 15,452 shares in the company, valued at approximately $591,039. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CFO Fred Hite sold 4,356 shares of the company’s stock in a transaction on Monday, June 26th. The stock was sold at an average price of $43.69, for a total transaction of $190,313.64. Following the completion of the sale, the chief financial officer now directly owns 97,267 shares in the company, valued at approximately $4,249,595.23. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Terry D. Schlotterback sold 2,610 shares of the stock in a transaction on Friday, August 11th. The shares were sold at an average price of $38.25, for a total value of $99,832.50. Following the completion of the sale, the director now owns 15,452 shares of the company’s stock, valued at $591,039. The disclosure for this sale can be found here. Insiders own 32.60% of the company’s stock.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
- Five stocks we like better than OrthoPediatrics
- What is the NASDAQ Stock Exchange?
- An Electrifying New Upgrade for Tesla Leads the Market Higher
- What is ChatGPT Stock? How to Invest in It
- Oil Jumps, 2 Plastic Stocks About To Become Value Plays
- Pros And Cons Of Monthly Dividend Stocks
- The Top 5 Analysts Calls in September
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.